Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Aung Naing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4803-8513; OpenAlex author ID A5005436649. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 trial · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 4

  1. Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Tri… Co-author DOI 10.1007/s12029-023-00930-7↗
  2. Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Last author DOI 10.1007/s10637-020-01000-6↗
  3. Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗
  4. Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. Co-author DOI 10.1002/cncr.25346↗

Trials 1

  1. Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Principal investigator NCT02159989↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shubham Pant · 2 shared papers, 2021–2023 · strength 0.27
  2. Robert A. Wolff · 3 shared papers, 2011–2023 · strength 0.25
  3. David S. Hong · 3 shared papers, 2011–2023 · strength 0.25
  4. Funda Meric-Bernstam · 2 shared papers, 2017–2023 · strength 0.22
  5. Vivek Subbiah · 2 shared papers, 2017–2023 · strength 0.22
  6. Jane Elizabeth Rogers · 1 shared paper, 2023 · strength 0.17
  7. Rishi Surana · 1 shared paper, 2023 · strength 0.17
  8. Jordi Ahnert Rodon · 1 shared paper, 2023 · strength 0.17
  9. Brandon George Smaglo · 1 shared paper, 2023 · strength 0.17
  10. Timothy Anthony Yap · 1 shared paper, 2023 · strength 0.17
  11. Milind M. Javle · 2 shared papers, 2017–2021 · strength 0.15
  12. Zev A. Wainberg · 1 shared paper, 2021 · strength 0.10
  13. Raid M. Aljumaily · 1 shared paper, 2021 · strength 0.10
  14. Manish R. Patel · 1 shared paper, 2021 · strength 0.10
  15. Todd Michael Bauer · 1 shared paper, 2021 · strength 0.10
  16. Joel Randolph Hecht · 1 shared paper, 2021 · strength 0.10
  17. Jeffrey R. Infante · 1 shared paper, 2021 · strength 0.10
  18. Johanna C. Bendell · 1 shared paper, 2021 · strength 0.10
  19. Apostolia Maria Tsimberidou · 2 shared papers, 2011–2017 · strength 0.08
  20. Sarina Anne Piha-Paul · 1 shared paper, 2017 · strength 0.05
  21. Jennifer Brooke Goldstein · 1 shared paper, 2017 · strength 0.05
  22. Chad Z. Tang · 1 shared paper, 2017 · strength 0.05
  23. Kenneth R. Hess · 1 shared paper, 2017 · strength 0.05
  24. Gauri Rajani Varadhachary · 1 shared paper, 2017 · strength 0.05
  25. David R. Fogelman · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.